Quanterix

Neurofilament Light Chain As A Biomarker For Chemotherapy-Induced Peripheral Neuropathy


Thanks for your interest in our webinar hosted in partnership with Nature Research! Unlock immediate access to the full recording by filling out the form.

What you’ll learn:

  • Can neurofilament light chain be used as an objective biomarker for chemotherapy-induced neurotoxicity in vitro?
  • Will neurofilament light chain be a biomarker for all types of chemotherapy-induced peripheral neuropathy?
  • What is the diagnostic and prognostic value of neurofilament light chain as a biomarker for chemotherapy-induced peripheral neuropathy

Complete the form and start watching now!


Speaker:
Tore B. Stage
Head of Research at Clinical Pharmacology, Pharmacy and Environmental Medicine University of Southern Denmark

Fill in the form below.

  • By submitting this form, you agree to Quanterix’s Terms of Use and Privacy Policy. In addition, you agree to receive information regarding Quanterix products and services. You will be able to unsubscribe at any time.

© 2025 Quanterix Corporation
 |  quanterix.com
 |  900 Middlesex Turnpike, Building 1
 | Billerica, MA 01821

  • facebook
  • x
  • linked in